NCT01280825 2026-03-04
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
University of Chicago
Recruiting
Clinical Trials
51 trialsNCT02422875 2025-09-30
Comparative Autoantibody and Immunologic Cell Marker Study
Emory University
Enrolling by invitation
NCT04525833 2025-09-19
Liver Disease and Other Systemic Diseases
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Recruiting
NCT02940496 2025-07-15
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT07038863 2025-06-26
Mondelta
Hospices Civils de Lyon
Phase NA Not yet recruiting
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT02935478 2025-02-06
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation
St. Louis University
Phase NA Suspended
NCT06745895 2024-12-20
MATCHES
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Recruiting
NCT06718530 2024-12-05
VERYMARKERS
Centro di Riferimento Oncologico - Aviano
Recruiting
NCT04540081 2023-12-27
CLOVER
University of California, Davis
Phase NA Completed
NCT02366286 2023-12-14
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants
Mayo Clinic
Completed
NCT05184283 2023-12-07
Utilization of MAsS in Patients Undergoing LT for HCC
Columbia University
Terminated
NCT05498779 2023-11-28
Ablation of Hepatocellular Carcinoma: a Nationwide Study
Rigshospitalet, Denmark
Completed
NCT03702998 2023-08-30
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
Chinese University of Hong Kong
Completed
NCT03903185 2023-08-22
Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy
Ain Shams University
Phase 1/2 Completed
NCT04653818 2023-04-04
RCT
Alexandria University
Phase 4 Completed
NCT04980157 2023-01-23
CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT04190498 2022-05-24
ECHAPS
University Hospital, Grenoble
Withdrawn
NCT05376943 2022-05-17
Possible Differences in HCC Course Depending on DAA Treatment
Medical University of Warsaw
Unknown
NCT05067374 2022-04-08
Mammo'C
University Hospital, Montpellier
Unknown
NCT02970136 2021-12-28
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
University of Miami
Phase NA Completed
NCT03200171 2021-07-21
Effect of DAAs on Behavior of HCC in HCV Patients
Al-Azhar University
Completed
NCT04037046 2021-04-30
Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening
University of La Laguna
Phase NA Completed
NCT03706742 2021-04-20
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
University of Texas Southwestern Medical Center
Phase NA Completed
NCT03254121 2021-02-18
HEPCASUS
Karolinska Institutet
Completed
NCT04090164 2020-10-19
Association of Hepatitis C Virus With Breast Cancer
Mansoura University
Completed
NCT01821963 2020-09-24
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT04395118 2020-07-02
STOP-HCC
University of Texas Southwestern Medical Center
Phase NA Withdrawn
NCT03109457 2020-02-05
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
Cairo University
Completed
NCT01619475 2019-02-08
A2ALL-2
Arbor Research Collaborative for Health
Completed
NCT02717949 2019-01-08
Optimal
University of Texas Southwestern Medical Center
Phase 4 Terminated
NCT03775798 2018-12-19
Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.
Austral University, Argentina
Unknown
NCT02833298 2018-10-12
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT00513461 2018-08-10
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
University of California, Irvine
Phase 2 Completed
NCT00096733 2017-08-29
A2ALL-1
Arbor Research Collaborative for Health
Completed
NCT03261349 2017-08-25
Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma
National Taiwan University Hospital
Phase 2 Unknown
NCT03197155 2017-06-23
RECAR
Hospices Civils de Lyon
Completed
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT00767936 2016-06-29
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford University
Terminated
NCT00897312 2016-04-25
Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Vanderbilt-Ingram Cancer Center
Terminated
NCT02588560 2015-10-28
Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy
Chang Gung Memorial Hospital
Unknown
NCT02113865 2015-03-09
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Completed
NCT01831037 2015-01-28
ROLFH
University of Arkansas
Withdrawn
NCT01405183 2014-09-17
Association Between Hepatitis C Infection and Renal Cell Carcinoma
Henry Ford Health System
Completed
NCT01729221 2012-11-20
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
Cairo University
Unknown
NCT00768001 2012-02-01
Genetic Analysis of Liver Cancer
Stanford University
Terminated
NCT01355107 2011-12-14
Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease
University Hospital Freiburg
Completed
NCT01360892 2011-05-26
PICTURE
Kindai University
Unknown
NCT00822991 2010-12-30
Sonazoid Enhanced Liver Cancer Trial for Early Detection
Kindai University
Phase NA Unknown
NCT00273247 2006-01-09
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
National Cancer Institute, Milan
Phase 3 Completed